BIODELIVERY SCIENCES INTERNATIONAL INC — key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2021)

$166.7M

Net Income/Loss (FY2021)

$84.9M

Total Assets (FY2021)

$324.6M

Total Equity (FY2021)

$187.8M

Cash Flows from Operating Activities (FY2021)

$41.0M

Source: BIODELIVERY SCIENCES INTERNATIONAL INC 10-K filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.